The file's text, extracted by GovTribe without its formatting.
Department of Defense United States Army Performance Work Statement
Olink ® Certified Service Provider
United States Army Research Institute of Environmental Medicine
Military Nutrition Division
PART 1
1.0 GENERAL INFORMATION
1.1 This is a non-personal services contract to provide assays conducted by an Olink ® certified service provider.
1.2 Description of services/introduction: The contractor shall provide all personnel, equipment, supplies, facilities, transportation, tools, materials, supervision, and other items and non-personal services necessary to perform Olink ® assays defined in this Performance Work Statement (PWS) except for those items specified as government furnished property and services. The contractor shall perform to the standards in this PWS.
1.3 Background: The Military Nutrition Division at the U.S. Army Research Institute of Environmental Medicine (USARIEM) requires services to analyze up to 88 biological samples collected in collaboration with the Norwegian Defense Force, for targeted protein metabolism, inflammation, and immune response panels.
1.4 Objectives: The objective of this requirement is to obtain analysis of up to 88 biological samples for required targets. The required targets are manufactured by Olink ® into single panels for metabolism, inflammation, and immune response analytes.
1.5 Scope: The services required are Olink ® technology assays. These assays use proximity extension assay technology, a highly specific and multiplexed method. Services include three specific Olink ® panel analyses for up to 88 samples each. These panels target metabolism, inflammation, and immune response biomarkers. The contractor shall accomplish running and analysis of all three panels for each of the samples provided (up to 88).
1.6 Period of Performance: 15 August 2026 – 14 August 2027
1.7 Administrative specifications
1.7.1 Place of performance: The work shall be performed at the contractor’s laboratory. USARIEM will ship the samples via FEDEX to the specified address once the contract is awarded.
1.7.2 Recognized Federal holidays: The contractor is not required to perform services on the following holidays:
| New Year’s Day | Labor Day | |
| Martin Luther King Jr.’s Birthday | Columbus Day President’s Day | Veteran’s Day |
| Memorial Day | Thanksgiving Day | |
| Juneteenth Day | Christmas Day Independence Day | |
1.7.3 Hours of operation: The contractor is responsible for conducting business Monday through Friday except Federal holidays or when the Government facility is closed due to local or national emergencies, administrative closings, or similar Government directed facility closings. The contractor must at all times maintain an adequate workforce for the uninterrupted performance of all tasks defined within this PWS when the Government facility is not closed for the above reasons.
1.7.4 Emergency Services: No emergency services will be required.
1.8 Contractor travel: There are no requirements for contractor travel.
1.9 Other Direct Costs: There are no other direct costs to be considered.
1.10 Quality
1.10.1 Quality Control (QC): The contractor shall develop and maintain an effective QC program to ensure services are performed in accordance with this PWS. The contractor shall develop and implement procedures to identify, prevent, and ensure nonrecurrence of defective services. The contractor’s QC program is the means by which the work complies with stated requirements. To assure precise and accurate results, the contractor must run both a positive and negative control on each panel along with calibrators.
1.10.2 Quality assurance: The government will evaluate the contractor’s performance under this contract in accordance with the Quality Assurance Surveillance Plan (QASP). This plan provides a systematic method for the Government to evaluate performance and to ensure that the contractor has performed in accordance with the performance standards. It defines how the performance standards will be applied, the frequency of surveillance, and the minimum acceptable defect rate(s).
1.11 Contractor personnel: There are no Common Access Card, physical security, or key requirements. All work is to take place at the contractors laboratory. No government facilities or equipment will be utilized.
1.11.1 Lock combinations: Reserved.
1.12 Key personnel (Contractor): Not applicable.
1.13 Data rights: All data produced from sample analysis belongs to the government. Data must be delivered to USARIEM via Excel or a similar program.
1.14 Reporting
1.14.1 Service Contract Reporting: RESERVED.
1.14.2 Non-Disclosure Agreement: Not applicable.
1.14.3 Government’s Contracting Officer’s Representative (COR): The COR monitors all technical aspects of the contract and assists in contract administration. The COR is authorized to perform the following functions: assure that the contractor performs the technical requirements of the contract; perform inspections necessary in connection with contract performance; maintain written and oral communications with the contractor concerning technical aspects of the contract; issue written interpretations of technical requirements, including Government drawings, designs, specifications; monitor contractor's performance and notifies both the Contracting Officer and contractor of any deficiencies; coordinate availability of government furnished property; and provide site entry of contractor personnel. A letter of designation issued to the COR, a copy of which is sent to the contractor, states the responsibilities and limitations of the COR, especially with regard to changes in cost or price, estimates or changes in delivery dates. The COR is not authorized to change any of the terms and conditions of the resulting contract.
1.15 Contractor Identification: Not applicable. No work by the contractor will take place in a government facility.
1.16 Contractor Access to Health Affairs (HA)/Defense Health Agency (DHA) Network(s): Not applicable. Contractors will not have or require access to HA/DHA networks.
PART 2
2.0 DEFINITIONS, ACRONYMS, AND APPLICABLE PUBLICATIONS/INSTRUCTIONS
2.1 Definitions:
2.1.1 Category D: Information Technology (IT) and Telecommunications Services (called D-Services)
2.1.2 Category R: Support (Professional/Administrative/Management) Services (called R-Services)
2.1.3 Contracting Officer: A person with the authority to enter into, administer, and/or terminate contracts and make related determinations and findings.
2.1.4 Contracting Officer’s Representative (COR): An individual designated and authorized in writing by the Contracting Officer to perform specific technical or administrative functions. This individual does NOT have authority to change the terms and conditions of the contract.
2.1.5 Nonpersonal services contract: a contract under which the personnel rendering the services are not subject, either by the contract’s terms or by the manner of its administration, to the supervision and control usually prevailing in relationships between the Government and its employees.
2.1.6 Quality Assurance Surveillance Plan (QASP): An organized written document specifying the surveillance methodology to be used for surveillance of contractor performance. The Government may either prepare the QASP or require the offerors to submit a proposed quality assurance surveillance plan for the Government’s consideration in development of the Government’s plan.
2.1.7 United States Army Research Institute of Environmental Medicine (USARIEM)
2.2 Acronyms:
| CDRL | Contract Data Requirement List |
| COR | Contracting Officer Representative |
| DHA | Defense Health Agency |
| DoD | Department of Defense |
| DSAs | Data Sharing Agreements |
| DSAA | Data Sharing Agreement Application |
| DPCLO | DHA Privacy and Civil Liberties Office |
| HA | Health Affairs |
| IT | Information Technology |
| MHS | Military Health System |
| PWS | Performance Work Statement |
| QASP | Quality Assurance Surveillance Plan |
| QC | Quality Control |
| QCP | Quality Control Plan |
2.3 Applicable Publications Not applicable
PART 3
3.0 GOVERNMENT FURNISHED PROPERTY, EQUIPMENT, AND SERVICES
The Requiring Activity Authority has assessed the need for Government Furnished Property, Equipment, and Services and determined:
3.1 Services: The Government:
Will NOT provide Government Furnished Services in support of this contract/task order. As a result, this paragraph is Not Applicable.
3.2 Facilities: The Government:
Will NOT provide Facilities in support of this contract/task order. As a result, this paragraph is Not Applicable.
3.3 Utilities: The Government:
Will NOT provide Utilities in support of this contract/task order. As a result, this paragraph is Not Applicable.
3.4 Equipment: The Government:
Will NOT provide Equipment in support of this contract/task order. As a result, this paragraph is Not Applicable.
3.5 Materials: The Government:
IS providing Materials in support of this contract/task orders. The Government-provided Materials are described below: Up to 88 biological samples, de-idenitifed and shipped on dry ice.
PART 4
4.0 CONTRACTOR FURNISHED ITEMS AND SERVICES
4.1 Services: The Contractor:
WILL provide Contractor Furnished Services required in support of this contract. These Services are described below: provide analysis of up to 88 biological samples for required targets. The required targets are manufactured by Olink ® into single panels for metabolism, inflammation, and immune response analytes.
4.2 General: The contractor shall furnish all supplies, equipment, facilities and services required to perform work listed under Section 5 of this PWS.
4.3 Secret Facility Clearance: Not applicable.
4.4 Materials: The contractor shall supply all reagents and consumables required to plate and assay up to 88 biological samples for Olink ® panels.
4.5 Equipment: The contractor shall provide all equipment for Olink ® panel reading and analysis.
4.6 Facilities: The contractor shall conduct all analyses within their Olink ® certified service provider laboratory.
PART 5
5.0 SPECIFIC TASKS
5.1 Olink Target 96 Certified Service Providers: USARIEM requires services to analyze up to 88 biological and de-identified samples that have been previously collected. The contractor shall analyze these samples for targeted protein metabolism, inflammation, and immune response panels using Olink ® technology.
5.1.1 Olink ® Target 96 Panels: Required targets for each panel are as follows:
Metabolism:
| UniProt ID |
| Gene |
| Protein name |
| P23526 |
| AHCY |
| Adenosylhomocysteinase |
| P25815 |
| S100P |
| Protein S100-P |
| P26010 |
| ITGB7 |
| Integrin beta-7 |
| P27695 |
| APEX1 |
| DNA-(apurinic or apyrimidinic site) endonuclease |
| P29017 |
| CD1C |
| T-cell surface glycoprotein CD1c |
| P35237 |
| SERPINB6 |
| Serpin B6 |
| P35754 |
| GLRX |
| Glutaredoxin-1 |
| P40259 |
| CD79B |
| B-cell antigen receptor complex-associated protein beta chain |
| P40818 |
| USP8 |
| Ubiquitin carboxyl-terminal hydrolase 8 |
| P22466 |
| GAL |
| Galanin peptides |
| P41236 |
| PPP1R2 |
| Protein phosphatase inhibitor 2 |
| P46109 |
| CRKL |
| Crk-like protein |
| P46379 |
| BAG6 |
| Large proline-rich protein BAG6 |
| P50452 |
| SERPINB8 |
| Serpin B8 |
| P50995 |
| ANXA11 |
| Annexin A11 |
| P51693 |
| APLP1 |
| Amyloid-like protein 1 |
| P51858 |
| HDGF |
| Hepatoma-derived growth factor |
| P52888 |
| THOP1 |
| Thimet oligopeptidase |
| P98082 |
| DAB2 |
| Disabled homolog 2 |
| Q01973 |
| ROR1 |
| Inactive tyrosine-protein kinase transmembrane receptor ROR1 |
| Q02790 |
| FKBP4 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 |
| Q03403 |
| TFF2 |
| Trefoil factor 2 |
| P21964 |
| COMT |
| Catechol O-methyltransferase |
| P19971 |
| TYMP |
| Thymidine phosphorylase |
| O00161 |
| SNAP23 |
| Synaptosomal-associated protein 23 |
| O15123 |
| ANGPT2 |
| Angiopoietin-2 |
| O43240 |
| KLK10 |
| Kallikrein-10 |
| O43827 |
| ANGPTL7 |
| Angiopoietin-related protein 7 |
| O75356 |
| ENTPD5 |
| Ectonucleoside triphosphate diphosphohydrolase 5 |
| O75791 |
| GRAP2 |
| GRB2-related adapter protein 2 |
| O95502 |
| NPTXR |
| Neuronal pentraxin receptor |
| O95841 |
| ANGPTL1 |
| Angiopoietin-related protein 1 |
| P20711 |
| DDC |
| Aromatic-L-amino-acid decarboxylase |
| P00352 |
| ALDH1A1 |
| Retinal dehydrogenase 1 |
| P09104 |
| ENO2 |
| Gamma-enolase |
| P09417 |
| QDPR |
| Dihydropteridine reductase |
| P09467 |
| FBP1 |
| Fructose-1,6-bisphosphatase 1 |
| P09668 |
| CTSH |
| Pro-cathepsin H |
| P12724 |
| RNASE3 |
| Eosinophil cationic protein |
| P13611 |
| VCAN |
| Versican core protein |
| P01222 |
| TSHB |
| Thyrotropin subunit beta |
| A6NI73 |
| LILRA5 |
| Leukocyte immunoglobulin-like receptor subfamily A member 5 |
| NT-proBNP |
| NT-proBNP |
| N-terminal prohormone of brain natriuretic peptide |
| P16083 |
| NQO2 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] |
| Q8WVQ1 |
| CANT1 |
| Soluble calcium-activated nucleotidase 1 |
| Q8WTU2 |
| SSC4D |
| Scavenger receptor cysteine-rich domain-containing group B protein |
| Q8NI22 |
| MCFD2 |
| Multiple coagulation factor deficiency protein 2 |
| Q8NBS9 |
| TXNDC5 |
| Thioredoxin domain-containing protein 5 |
| Q8NBJ7 |
| SUMF2 |
| Inactive C-alpha-formylglycine-generating enzyme 2 |
| Q8N1Q1 |
| CA13 |
| Carbonic anhydrase 13 |
| Q8IZP9 |
| ADGRG2 |
| Adhesion G-protein coupled receptor G2 |
| Q86VZ4 |
| LRP11 |
| Low-density lipoprotein receptor-related protein 11 |
| Q76M96 |
| CCDC80 |
| Coiled-coil domain-containing protein 80 |
| Q6WN34 |
| CHRDL2 |
| Chordin-like protein 2 |
| Q6UWV6 |
| ENPP7 |
| Ectonucleotide pyrophosphatase/phosphodiesterase family member 7 |
| Q16820 |
| MEP1B |
| Meprin A subunit beta |
| Q16773 |
| KYAT1 |
| Kynurenine--oxoglutarate transaminase 1 |
| Q15846 |
| CLUL1 |
| Clusterin-like protein 1 |
| Q15155 |
| NOMO1 |
| Nodal modulator 1 |
| Q13275 |
| SEMA3F |
| Semaphorin-3F |
| Q06418 |
| TYRO3 |
| Tyrosine-protein kinase receptor TYRO3 |
| Q8WX77 |
| IGFBPL1 |
| Insulin-like growth factor-binding protein-like 1 |
| Q04900 |
| CD164 |
| Sialomucin core protein 24 |
| Q92520 |
| FAM3C |
| Protein FAM3C |
| Q96JA1 |
| LRIG1 |
| Leucine-rich repeats and immunoglobulin-like domains protein 1 |
| Q9Y286 |
| SIGLEC7 |
| Sialic acid-binding Ig-like lectin 7 |
| Q9UKJ0 |
| PILRB |
| Paired immunoglobulin-like type 2 receptor beta |
| Q9UHX3 |
| ADGRE2 |
| Adhesion G protein-coupled receptor E2 |
| Q9UHL4 |
| DPP7 |
| Dipeptidyl peptidase 2 |
| Q9UBU3 |
| GHRL |
| Appetite-regulating hormone |
| Q9NY25 |
| CLEC5A |
| C-type lectin domain family 5 member A |
| Q9NWQ8 |
| PAG1 |
| Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 |
| Q9NR28 |
| DIABLO |
| Diablo homolog, mitochondrial |
| Q9NQX5 |
| NPDC1 |
| Neural proliferation differentiation and control protein 1 |
| Q9HBB8 |
| CDHR5 |
| Cadherin-related family member 5 |
| Q9H6B4 |
| CLMP |
| CXADR-like membrane protein |
| Q9H4D0 |
| CLSTN2 |
| Calsyntenin-2 |
| Q9GZM7 |
| TINAGL1 |
| Tubulointerstitial nephritis antigen-like |
| Q9BZR6 |
| RTN4R |
| Reticulon-4 receptor |
| Q9BYZ8 |
| REG4 |
| Regenerating islet-derived protein 4 |
| Q96LA6 |
| FCRL1 |
| Fc receptor-like protein 1 |
| Q9NPH0 |
| ACP6 |
| Lysophosphatidic acid phosphatase type 6 |
| Q9Y5K6 |
| CD2AP |
| CD2-associated protein |
| Q641Q3 |
| METRNL |
| Meteorin-like protein |
Inflammation:
| UniProt ID |
| Gene |
| Protein name |
| P30203 |
| CD6 |
| T-cell differentiation antigen CD6 |
| Q14116 |
| IL18 |
| Interleukin-18 |
| Q13291 |
| SLAMF1 |
| Signaling lymphocytic activation molecule |
| P01135 |
| TGFA |
| Protransforming growth factor alpha |
| Q99616 |
| CCL13 |
| C-C motif chemokine 13 |
| O43557 |
| TNFSF14 |
| Tumor necrosis factor ligand superfamily member 14 |
| Q9GZV9 |
| FGF23 |
| Fibroblast growth factor 23 |
| Q13651 |
| IL10RA |
| Interleukin-10 receptor subunit alpha |
| P13236 |
| CCL4 |
| C-C motif chemokine 4 |
| P12034 |
| FGF5 |
| Fibroblast growth factor 5 |
| P42702 |
| LIFR |
| Leukemia inhibitory factor receptor |
| Q9NSA1 |
| FGF21 |
| Fibroblast growth factor 21 |
| Q99731 |
| CCL19 |
| C-C motif chemokine 19 |
| Q13261 |
| IL15RA |
| Interleukin-15 receptor subunit alpha |
| Q08334 |
| IL10RB |
| Interleukin-10 receptor subunit beta |
| Q8N6P7 |
| IL22RA1 |
| Interleukin-22 receptor subunit alpha-1 |
| Q13478 |
| IL18R1 |
| Interleukin-18 receptor 1 |
| Q9NZQ7 |
| CD274 |
| Programmed cell death 1 ligand 1 |
| P01138 |
| NGF |
| Beta-nerve growth factor |
| P42830 |
| CXCL5 |
| C-X-C motif chemokine 5 |
| P03956 |
| MMP1 |
| Interstitial collagenase |
| O14788 |
| TNFSF11 |
| Tumor necrosis factor ligand superfamily member 11 |
| Q969D9 |
| TSLP |
| Thymic stromal lymphopoietin |
| P15692 |
| VEGFA |
| Vascular endothelial growth factor A |
| P80098 |
| CCL7 |
| C-C motif chemokine 7 |
| P39905 |
| GDNF |
| Glial cell line-derived neurotrophic factor |
| Q9H5V8 |
| CDCP1 |
| CUB domain-containing protein 1 |
| Q9BZW8 |
| CD244 |
| Natural killer cell receptor 2B4 |
| O00300 |
| TNFRSF11B |
| Tumor necrosis factor receptor superfamily member 11B |
| P01137 |
| TGFB1 |
| Transforming growth factor beta-1 proprotein |
| P00749 |
| PLAU |
| Urokinase-type plasminogen activator |
| P09341 |
| CXCL1 |
| Growth-regulated alpha protein |
| Q9P0M4 |
| IL17C |
| Interleukin-17C |
| Q16552 |
| IL17A |
| Interleukin-17A |
| O14625 |
| CXCL11 |
| C-X-C motif chemokine 11 |
| P50591 |
| TNFSF10 |
| Tumor necrosis factor ligand superfamily member 10 |
| Q9UHF4 |
| IL20RA |
| Interleukin-20 receptor subunit alpha |
| Q07325 |
| CXCL9 |
| C-X-C motif chemokine 9 |
| P14784 |
| IL2RB |
| Interleukin-2 receptor subunit beta |
| P01583 |
| IL1A |
| Interleukin-1 alpha |
| P13500 |
| CCL2 |
| C-C motif chemokine 2 |
| P10145 |
| CXCL8 |
| Interleukin-8 |
| Q8NFT8 |
| DNER |
| Delta and Notch-like epidermal growth factor-related receptor |
| Q9NRJ3 |
| CCL28 |
| C-C motif chemokine 28 |
| Q8IXJ6 |
| SIRT2 |
| NAD-dependent protein deacetylase sirtuin-2 |
| Q9NYY1 |
| IL20 |
| Interleukin-20 |
| Q13541 |
| EIF4EBP1 |
| Eukaryotic translation initiation factor 4E-binding protein 1 |
| P02778 |
| CXCL10 |
| C-X-C motif chemokine 10 |
| P80162 |
| CXCL6 |
| C-X-C motif chemokine 6 |
| P49771 |
| FLT3LG |
| Fms-related tyrosine kinase 3 ligand |
| P80511 |
| S100A12 |
| Protein S100-A12 |
| P10147 |
| CCL3 |
| C-C motif chemokine 3 |
| P55773 |
| CCL23 |
| C-C motif chemokine 23 |
| P01375 |
| TNF |
| Tumor necrosis factor |
| P22301 |
| IL10 |
| Interleukin-10 |
| P09238 |
| MMP10 |
| Stromelysin-2 |
| P35225 |
| IL13 |
| Interleukin-13 |
| Q13007 |
| IL24 |
| Interleukin-24 |
| P29460 |
| IL12B |
| Interleukin-12 subunit beta |
| P06127 |
| CD5 |
| T-cell surface glycoprotein CD5 |
| P14210 |
| HGF |
| Hepatocyte growth factor |
| P25942 |
| CD40 |
| Tumor necrosis factor receptor superfamily member 5 |
| P01579 |
| IFNG |
| Interferon gamma |
| P09603 |
| CSF1 |
| Macrophage colony-stimulating factor 1 |
| P01374 |
| LTA |
| Lymphotoxin-alpha |
| P00813 |
| ADA |
| Adenosine deaminase |
| O95630 |
| STAMBP |
| STAM-binding protein |
| P50225 |
| SULT1A1 |
| Sulfotransferase 1A1 |
| P78556 |
| CCL20 |
| C-C motif chemokine 20 |
| O43508 |
| TNFSF12 |
| Tumor necrosis factor ligand superfamily member 12 |
| O95760 |
| IL33 |
| Interleukin-33 |
| P20783 |
| NTF3 |
| Neurotrophin-3 |
| P78423 |
| CX3CL1 |
| Fractalkine |
| O15444 |
| CCL25 |
| C-C motif chemokine 25 |
| P80075 |
| CCL8 |
| C-C motif chemokine 8 |
| P15018 |
| LIF |
| Leukemia inhibitory factor |
| O95750 |
| FGF19 |
| Fibroblast growth factor 19 |
| Q07011 |
| TNFRSF9 |
| Tumor necrosis factor receptor superfamily member 9 |
| P01732 |
| CD8A |
| T-cell surface glycoprotein CD8 alpha chain |
Immune Response:
| UniProt ID |
| Gene |
| Protein name |
| P28845 |
| HSD11B1 |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 |
| P30044 |
| PRDX5 |
| Peroxiredoxin-5 |
| P30048 |
| PRDX3 |
| Thioredoxin-dependent peroxide reductase |
| P34130 |
| NTF4 |
| Neurotrophin-4 |
| P42701 |
| IL12RB1 |
| Interleukin-12 receptor subunit beta-1 |
| P48061 |
| CXCL12 |
| Stromal cell-derived factor 1 |
| P48740 |
| MASP1 |
| Mannan-binding lectin serine protease 1 |
| P50135 |
| HNMT |
| Histamine N-methyltransferase |
| P51617 |
| IRAK1 |
| Interleukin-1 receptor-associated kinase 1 |
| P52823 |
| STC1 |
| Stanniocalcin-1 |
| P58499 |
| FAM3B |
| Protein FAM3B |
| P63241 |
| EIF5A |
| Eukaryotic translation initiation factor 5A-1 |
| P78310 |
| CXADR |
| Coxsackievirus and adenovirus receptor |
| P78362 |
| SRPK2 |
| SRSF protein kinase 2 |
| P78410 |
| BTN3A2 |
| Butyrophilin subfamily 3 member A2 |
| Q03431 |
| PTH1R |
| Parathyroid hormone/parathyroid hormone-related peptide receptor |
| Q04637 |
| EIF4G1 |
| Eukaryotic translation initiation factor 4 gamma 1 |
| Q04759 |
| PRKCQ |
| Protein kinase C theta type |
| Q05084 |
| ICA1 |
| Islet cell autoantigen 1 |
| P23229 |
| ITGA6 |
| Integrin alpha-6 |
| P27540 |
| ARNT |
| Aryl hydrocarbon receptor nuclear translocator |
| P19474 |
| TRIM21 |
| E3 ubiquitin-protein ligase TRIM21 |
| O14867 |
| BACH1 |
| Transcription regulator protein BACH1 |
| O43597 |
| SPRY2 |
| Protein sprouty homolog 2 |
| O43736 |
| ITM2A |
| Integral membrane protein 2A |
| O60449 |
| LY75 |
| Lymphocyte antigen 75 |
| O60880 |
| SH2D1A |
| SH2 domain-containing protein 1A |
| O75475 |
| PSIP1 |
| PC4 and SFRS1-interacting protein |
| O76036 |
| NCR1 |
| Natural cytotoxicity triggering receptor 1 |
| O94992 |
| HEXIM1 |
| Protein HEXIM1 |
| O95786 |
| RIGI |
| Antiviral innate immune response receptor RIG-I |
| P22301 |
| IL10 |
| Interleukin-10 |
| O00273 |
| DFFA |
| DNA fragmentation factor subunit alpha |
| P05412 |
| JUN |
| Transcription factor AP-1 |
| P09038 |
| FGF2 |
| Fibroblast growth factor 2 |
| P10747 |
| CD28 |
| T-cell-specific surface glycoprotein CD28 |
| P14317 |
| HCLS1 |
| Hematopoietic lineage cell-specific protein |
| P16278 |
| GLB1 |
| Beta-galactosidase |
| P16455 |
| MGMT |
| Methylated-DNA--protein-cysteine methyltransferase |
| P18564 |
| ITGB6 |
| Integrin beta-6 |
| P18627 |
| LAG3 |
| Lymphocyte activation gene 3 protein |
| P52294 |
| KPNA1 |
| Importin subunit alpha-5 |
| Q00978 |
| IRF9 |
| Interferon regulatory factor 9 |
| Q8N608 |
| DPP10 |
| Inactive dipeptidyl peptidase 10 |
| Q8IU57 |
| IFNLR1 |
| Interferon lambda receptor 1 |
| Q6ZUJ8 |
| PIK3AP1 |
| Phosphoinositide 3-kinase adapter protein 1 |
| Q6UXB4 |
| CLEC4G |
| C-type lectin domain family 4 member G |
| Q6EIG7 |
| CLEC6A |
| C-type lectin domain family 6 member A |
| Q6DN72 |
| FCRL6 |
| Fc receptor-like protein 6 |
| Q15661 |
| TPSAB1 |
| Tryptase alpha/beta-1 |
| Q8NHJ6 |
| LILRB4 |
| Leukocyte immunoglobulin-like receptor subfamily B member 4 |
| Q15517 |
| CDSN |
| Corneodesmosin |
| Q14203 |
| DCTN1 |
| Dynactin subunit 1 |
| Q13574 |
| DGKZ |
| Diacylglycerol kinase zeta |
| Q13490 |
| BIRC2 |
| Baculoviral IAP repeat-containing protein 2 |
| Q13241 |
| KLRD1 |
| Natural killer cells antigen CD94 |
| Q12968 |
| NFATC3 |
| Nuclear factor of activated T-cells |
| Q12933 |
| TRAF2 |
| TNF receptor-associated factor 2 |
| Q07065 |
| CKAP4 |
| Cytoskeleton-associated protein 4 |
| Q06830 |
| PRDX1 |
| Peroxiredoxin-1 |
| Q14435 |
| GALNT3 |
| Polypeptide N-acetylgalactosaminyltransferase 3 |
| Q05516 |
| ZBTB16 |
| Zinc finger and BTB domain-containing protein 16 |
| Q8WTT0 |
| CLEC4C |
| C-type lectin domain family 4 member C |
| Q92844 |
| TANK |
| TRAF family member-associated NF-kappa-B activator |
| Q9Y2J8 |
| PADI2 |
| Protein-arginine deiminase type-2 |
| Q9UQV4 |
| LAMP3 |
| Lysosome-associated membrane glycoprotein 3 |
| Q9UQQ2 |
| SH2B3 |
| SH2B adapter protein 3 |
| Q9UNE0 |
| EDAR |
| Tumor necrosis factor receptor superfamily member EDAR |
| Q9UN19 |
| DAPP1 |
| Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide |
| Q9UMR7 |
| CLEC4A |
| C-type lectin domain family 4 member A |
| Q9UKX5 |
| ITGA11 |
| Integrin alpha-11 |
| Q9UHC6 |
| CNTNAP2 |
| Contactin-associated protein-like 2 |
| Q8WXI8 |
| CLEC4D |
| C-type lectin domain family 4 member D |
| Q9NWZ3 |
| IRAK4 |
| Interleukin-1 receptor-associated kinase 4 |
| Q9GZT9 |
| EGLN1 |
| Egl nine homolog 1 |
| Q9C035 |
| TRIM5 |
| Tripartite motif-containing protein 5 |
| Q9BXN2 |
| CLEC7A |
| C-type lectin domain family 7 member A |
| Q96SB3 |
| PPP1R9B |
| Neurabin-2 |
| Q96P31 |
| FCRL3 |
| Fc receptor-like protein 3 |
| Q96DB9 |
| FXYD5 |
| FXYD domain-containing ion transport regulator 5 |
| Q9NP99 |
| TREM1 |
| Triggering receptor expressed on myeloid cells 1 |
| Q9Y3P8 |
| SIT1 |
| Signaling threshold-regulating transmembrane adapter 1 |
5.1.2 Sample Preparation: The contractor must be able to maintain cold chain receipt of samples along with storage at -80℃ while not in use. The USARIEM will provide one aliquot of deidentified Ethylenediaminetetraacetic acid (EDTA) plasma > 100 ul for each of the 88 samples, and the contractor must be able to plate all three panels from the single aliquot on one freeze / thaw cycle.
5.1.3 Sample Testing and quality control: The contractor must run a positive and negative control along with calibrators on each plate. All samples provided by USARIEM (up to 88) must be run on a single plate for each panel. Results must be delivered by the end of the period of performance.
5.1.4 Data analysis and reporting: Results shall be analyzed and provided to the USARIEM in excel or a similar program with outcomes reported in normalized protein expression values (NPXs).
5.1.5 Sample return: Any remaining sample(s) must be returned to USARIEM in the original cryovial provided, and cold chain logistics must be maintained with the samples being returned on dry ice by an appropriate shipping company. Shipping arrangement and expenses for returning samples are to be the Contractor’s responsibility.
5.2 Special Qualifications: The contractor must be an Olink Certified Service Provider, indicating the organization has undergone training, annual concordance testing, and re-certification to demonstrate their ability to consistently perform Olink workflows with the highest quality.
PART 6
6.0 INFORMATION TECHNOLOGY & SECURITY
6.1 All work under this contract is unclassified.
6.2 Personally Identifiable Information/Protected Health Information, Procurement, and Federal information requirements: Not applicable
6.3 Training
6.3.1 Contractor employees performing cybersecurity/cyberspace functions shall comply with the following requirements: Not applicable
6.4 Cybersecurity Requirements for Non-Department of Defense (DoD) IT or Covered Contractor IS: Not applicable
6.5 Risk Management Framework for DoD IT: Not applicable
6.7. Facility Related Control Systems: Not applicable
6.8. System Communications - RESERVED
6.9 MHS Demilitarized Zone Medical Community of Interest Business-to-Business Gateway: Not applicable
6.10 Contractor Provided IT Infrastructure: Not applicable
6.11 System Authorization Access Request (SAAR), Defense Department (DD) Form 2875: Not applicable
6.12 MHS Systems Telecommunications: Not applicable
6.13 Establishment of Telecommunications: Not applicable.
6.14 Contractors Located On Military Installations: Not applicable
PART 7
7.0 TECHNICAL EXHIBIT LISTING
PART 7, TECHNICAL EXHIBIT 1 DELIVERABLES SCHEDULE
| Deliverable |
| Frequency |
| Medium/Format |
| Submit To |
| Applicable to: |
Data results shall be analyzed and provided to USARIEM with outcomes reported in normalized protein expression values (NPXs).
| Once during the life of the contract |
| Excel or similar program |
| COR |
| All, See PWS section 5 |